1. Home
  2. UVSP vs CRVS Comparison

UVSP vs CRVS Comparison

Compare UVSP & CRVS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

UVSP

Univest Financial Corporation

HOLD

Current Price

$43.14

Market Cap

1.2B

Sector

Finance

ML Signal

HOLD

Logo Corvus Pharmaceuticals Inc.

CRVS

Corvus Pharmaceuticals Inc.

HOLD

Current Price

$15.10

Market Cap

1.1B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
UVSP
CRVS
Founded
1876
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
1.2B
1.1B
IPO Year
1994
2016

Fundamental Metrics

Financial Performance
Metric
UVSP
CRVS
Price
$43.14
$15.10
Analyst Decision
Hold
Strong Buy
Analyst Count
3
6
Target Price
$36.67
$30.17
AVG Volume (30 Days)
260.9K
815.8K
Earning Date
04-22-2026
05-07-2026
Dividend Yield
2.44%
N/A
EPS Growth
21.32
48.04
EPS
1.78
N/A
Revenue
$328,056,000.00
N/A
Revenue This Year
$11.65
N/A
Revenue Next Year
$4.77
N/A
P/E Ratio
$24.12
N/A
Revenue Growth
9.64
N/A
52 Week Low
$28.04
$4.92
52 Week High
$45.46
$26.95

Technical Indicators

Market Signals
Indicator
UVSP
CRVS
Relative Strength Index (RSI) 46.76 63.50
Support Level $42.55 $14.24
Resistance Level $43.26 $16.66
Average True Range (ATR) 0.75 0.70
MACD -0.26 0.16
Stochastic Oscillator 33.23 93.45

Price Performance

Historical Comparison
UVSP
CRVS

About UVSP Univest Financial Corporation

Univest Financial Corp is engaged in domestic banking services for individuals, businesses, municipalities and non-profit organizations. The bank has three operating segments; Banking segment provides financial services including a full range of banking services such as deposit taking, loan origination, and servicing, mortgage banking, other general banking services, and equipment lease financing, Wealth Management segment offers investment advisory, financial planning, trust and brokerage services, and The Insurance segment includes a full-service insurance brokerage agency offering commercial property and casualty insurance, employee benefits solutions, personal insurance lines and human resources consulting. It generates majority of its revenue from the banking segment.

About CRVS Corvus Pharmaceuticals Inc.

Corvus Pharmaceuticals Inc is a clinical stage biopharmaceutical company developing product candidates that precisely target proteins that are critical to immune cell maturation and function. It believes its proprietary product candidates have broad potential to address immune mediated diseases, inflammatory diseases and cancers. Its product candidate, soquelitinib, is designed to bind specifically to a protein, interleukin 2 inducible T cell kinase (ITK), involved in T cell activation, T cell receptor signaling and T cell differentiation and function. The company operates in one primary business activity and operate as one reportable segment.

Share on Social Networks: